Navigation Links
Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
Date:12/15/2009

licensing agreements that shape the global market.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

The scope of this report includes:

  • Annualized market data for the HIV therapeutics market from 2000 to 2008, forecast forward to 2015
  • Analysis of the HIV therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan
  • Market characterization of the HIV therapeutics market including market size, annual cost of therapy, sales volume and treatment usage patterns
  • Key drivers and barriers that have a significant impact on the market
  • Coverage of pipeline molecules in various phases of drug development
  • Competitive benchmarking of leading companies. The key companies studied in this report are Gilead Sciences Inc, GlaxoSmithKline, Bristol-Myers Squibb, Abbott Laboratories, Merck & Co and Pfizer Inc
  • Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global HIV therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to:

  • Align product portfolio to the markets with high growth potential
  • Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth
  • Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety
  • Develop key strategic initiatives by understanding key focus areas of leading companies
  • Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

<
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... -- Regen BioPharma, Inc. (OTCBB: RGBP) and (PINK: ... of delivering its patented (US Patent 8,263,571) gene ... a clinically approved formulation as delivery system.  The ... silencing therapeutics in which the gene silencing drug ... By utilizing a local delivery system, potential toxicities ...
(Date:8/31/2015)... , Aug. 31, 2015  Soligenix, ... late-stage biopharmaceutical company developing products that address unmet ... and biodefense, announced today it has completed enrollment ... Data Review Committee (DRC) earlier this year, into ... is a first-in-class innate defense regulator (IDR) and ...
(Date:8/31/2015)... , Aug. 31, 2015  QT Vascular Ltd., together with ... together with its subsidiaries, the "Group"), a global ... of advanced therapeutic solutions for the minimally invasive ... results of the below-the-knee ("BTK") cohort of patients ... were presented on August 15, 2015 at the ...
Breaking Medicine Technology:Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4
... levels were significantly higher in patients with osteosarcoma than ... Biological Trace Element Research (April 2009). Osteosarcoma, ... young adults.Randhu and colleagues measured serum fluoride levels in ... one had osteosarcoma, group two had non-osteosarcoma bone tumors, ...
... U.S. Agency for International Development (USAID) is convening a ... Ethiopia, in a regional exercise that will kick off ... The three-day exercise seeks to advance global capacity ... a pandemic. As recently emphasized by outbreaks of swine ...
Cached Medicine Technology:Another Study Links Fluoride to Bone Cancer 2USAID Cooperates in Pandemic Preparedness Initiative 2USAID Cooperates in Pandemic Preparedness Initiative 3
(Date:8/31/2015)... ... August 31, 2015 , ... MeYou Health ®, a social well-being company ... app, Walkadoo , by including an in-app step tracker. , Walkadoo is a ... walking habits. Rather than broadly assign every Walkadoo member 10,000 steps a day (as ...
(Date:8/31/2015)... ... August 31, 2015 , ... The ... the use of health IT to create efficiencies in healthcare information exchange, announces ... . Taking place at the Hyatt Regency Reston in Reston, Va. from October ...
(Date:8/31/2015)... ... August 31, 2015 , ... It’s a lot like ... director of GreenFields of Geneva. During his first days on the job, he’s run ... nice seeing them, and I like knowing that they’re living in such a wonderful ...
(Date:8/31/2015)... ... August 31, 2015 , ... The ... Talent Management Division , a department devoted to helping organizations identify and keep ... goes beyond selection, and The Brooks Group believes in offering a solution that ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... Commerce Exchange and Organization Supporting Business Owners and provided a tour of their ... Georgia, represents the success possible to international companies expanding business in the U.S. ...
Breaking Medicine News(10 mins):Health News:Walkadoo™ Walking Program Now Includes In-app Step Tracker 2Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 2Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 3Health News:Friendship Senior Options Welcomes New Executive Director for GreenFields of Geneva 2Health News:The Brooks Group Introduces Talent Management Division 2Health News:The Brooks Group Introduces Talent Management Division 3Health News:PartnerTech Supports Economic Growth as Host 2
... HealthDay Reporter , TUESDAY, Oct. 25 (HealthDay News) ... cantaloupes produced at a Colorado farm has reached 28, with ... late Tuesday. Officials said last week that the outbreak ... farm. Inspections on Sept. 22 and 23 ...
... potential leukemia therapy targets only cancer cells, while leaving ... cancer cells and healthy cells, causing significant side effects, ... This research is being presented at the 2011 ... Exposition in Washington, D.C., Oct. 23 27. ...
... both men and women, yet men remain underrepresented in research. A ... has found that the medical impact of the disorder is ... research has shown that the number of men seeking treatment is ... is closely linked to obesity and excessive weight gain as well ...
... high proportion of dense breast tissue, as seen with a ... But the role of non-dense fat tissue in the breast ... access journal Breast Cancer Research separates the breast ... shows that large areas of either are independently associated with ...
... TUESDAY, Oct. 25 (HealthDay News) -- Men with a history ... for lung cancer could benefit from a simultaneous check for ... estimated that smoking will cause more than 8 million deaths ... addition to cardiovascular disease and cancer, COPD is a major ...
... activity and cancer prevention, treatment recovery and survivorship have ... component in the treatment of a disease that claims ... to the American Cancer Society,s Global Facts and Figures. ... and Cancer, Dr. Kerry Courneya, is one of the ...
Cached Medicine News:Health News:Death Toll From Listeria Outbreak Hits 28 2Health News:Death Toll From Listeria Outbreak Hits 28 3Health News:Study shows why underrepresented men should be included in binge eating research 2Health News:CT Scans May Pick Up COPD Early in Smokers 2Health News:CT Scans May Pick Up COPD Early in Smokers 3Health News:Canada Research Chair renewal for Kerry Courneya 2Health News:Canada Research Chair renewal for Kerry Courneya 3
The Genesis Camera meets the needs of those with specific requirements that cannot be met by a conventional 'chinrest' type camera....
Eye Q PRO is the optimum choice for ophthalmologists and clinicians specializing in advanced pathology and research....
Auto Lensmeter LM-970...
... designed to eliminate the subjective nature of ... providing repeatable, objective measurements every time. The ... icon-based operating system ensure fast and simple ... optimal lens positioning and, in auto mode, ...
Medicine Products: